Another COVID-19 resource, on vaccines

By STAT

  • Part 1: Antibody drugs that target the coronavirus: A conversation with George Yancopoulos, the co-founder, president, and chief scientific officer of Regeneron, on their antibody drugs in development to treat Covid-19.
  • Part 2: Fighting on multiple fronts: A discussion with Mikael Dolsten, the chief scientific officer of Pfizer, on the multiple routes the company is taking to fight Covid-19.
  • Part 3: Vaccines — can they come soon enough? With a sponsor introduction by Clem Lewin, Ph.D., associate vice president of R&D strategy for vaccines at Sanofi, as well as Tal Zaks, chief medical officer at Moderna and Matthew Herper, senior writer, medicine, and editorial director of events at STAT

Feel free to share your opinion below. (Note that I do screen comments on this website.)

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

This site uses Akismet to reduce spam. Learn how your comment data is processed.